Document is current
Any future updates will be listed below
-
Authors
Barnard, Mollie E.
Qin, Bo
Emerson, Marc A.
Holder, Etienne X.
Dunn, Matthew R.
Sarkar, Shromona
Xu, Nuo N.
Li, Yutong
Ambrosone, Christine B.
Bandera, Elisa V.
Palmer, Julie R.
Troester, Melissa A.
Hyslop, Terry
,
Pierce, Lori J.
Carey, Lisa A.
Davis, Melissa B.
Hershman, Dawn L.
Newman, Lisa A.
Perou, Charles M.
Bower, Julienne E.
Gomez, Scarlett
Hyslop, Terry
Pearce, Celeste Leigh
Malhotra, Priya
El-Ashry, Dorraya
Garber, Judy E.
Norton, Larry
-
Funding
Funding for this research was provided by:
American Cancer Society (RSG-24-1321373-01-ESED, RSG-23-1143513-01-CTPS)
Karin Grunebaum Cancer Research Foundation
Susan G. Komen (ASP231042218, OG22873776, SAC220228, OG22873776, OG22873776)
National Institutes of Health (T32 CA116339, P50 CA058223, R01 CA100598, R01 CA185623, U01 CA164974, P50 CA058223, P50 CA058223)
Breast Cancer Research Foundation
U.S. Department of Defense (HT94252310235)
- License Information
-
More Information
Article History
Received: 21 May 2025
Accepted: 22 July 2025
First Online: 6 August 2025
Competing interests
: Author EVB served as member of Pfizer’s Advisory Board to enhance minority participation in clinical trials (7/2021-8/2023). All other authors declare no financial or non-financial competing interests.
